Astrana Health, Inc. (ASTH) stock
ASTHNasdaqServices-Management Consulting ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/308% below fair value
$31.77−1.17 (-3.55%)
Close on Nov 12, 2026Market cap $1.77BP/E 29.7Yield –
Astrana Health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Astrana Health's ebitda for the twelve months ending Sep 30, 2026 was $184.18M, up 87.3% year over year. For fiscal 2025 it was $124.27M, up 6.0% from the year before. The highest annual figure on record is $124.27M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $124.27M | +6.0% |
| FY2024 | Dec 31, 2024 | $117.28M | +14.6% |
| FY2023 | Dec 31, 2023 | $102.36M | -16.0% |
| FY2022 | Dec 31, 2022 | $121.81M | +5.3% |
| FY2021 | Dec 31, 2021 | $115.70M | +17.0% |
| FY2020 | Dec 31, 2020 | $98.85M | +95.0% |
| FY2019 | Dec 31, 2019 | $50.70M | -52.9% |
| FY2018 | Dec 31, 2018 | $107.74M | – |
| FY2016 | Mar 31, 2016 | -$6.91M | – |
| FY2014 | Jan 31, 2014 | -$3.88M | – |
| FY2013 | Jan 31, 2013 | -$2.06M | – |
| FY2012 | Jan 31, 2012 | -$400.75K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | $55.50M | +59.5% |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $49.87M | +83.1% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $44.01M | +60.4% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $34.80M | +293.4% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $34.81M | -2.5% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $27.24M | -27.4% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $27.43M | -22.1% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $8.85M | +757.2% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $35.69M | -17.7% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $37.51M | +19.9% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $35.24M | +32.1% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $1.03M | -93.8% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $43.39M | -20.9% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $31.28M | +58.5% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $26.67M | -12.8% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $16.64M | +149.9% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $54.85M | -5.2% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $19.73M | -21.8% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $30.59M | +17.7% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $6.66M | -78.0% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $57.83M | +37.6% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $25.23M | +43.9% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $25.98M | +186.5% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $30.22M | +96.0% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $42.03M | +180.5% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $17.53M | -8.6% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $9.07M | +716.1% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $15.42M | +137.7% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $14.99M | -75.6% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $19.18M | +59.0% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $1.11M | -96.0% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $6.49M | – |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | $61.42M | – |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $12.07M | – |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | $27.76M | – |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | -$3.66M | – |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | -$1.31M | – |
| Q2 FY2016CQ3 2015 | Sep 30, 2015 | -$335.22K | – |
| Q1 FY2016CQ2 2015 | Jun 30, 2015 | -$1.60M | – |
| Q4 FY2014CQ4 2013 | Jan 31, 2014 | -$1.01M | – |
See a number that looks wrong?